Dalbavancin in Real Life: Economic Impact of Prescription Timing in French Hospitals

INTRODUCTION: The extended half-life of dalbavancin justifies a once-a-week dosing schedule and is supposed to favour early discharge. These advantages may therefore compensate for the cost of dalbavancin, but no real-life assessment has been conducted to date. We aimed to assess the real-life budge...

Descripción completa

Detalles Bibliográficos
Autores principales: Béraud, Guillaume, Maupetit, Jean-Claude, Darras, Audric, Vimont, Alexandre, Blachier, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847654/
https://www.ncbi.nlm.nih.gov/pubmed/34913137
http://dx.doi.org/10.1007/s40121-021-00577-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847654/
https://www.ncbi.nlm.nih.gov/pubmed/34913137
http://dx.doi.org/10.1007/s40121-021-00577-6

Ejemplares similares